文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

优化EUS引导下胆管十二指肠吻合术联合腔道适配金属支架用于恶性远端胆道梗阻的一线引流(SCORPION-IIp):一项前瞻性先导研究

Optimizing EUS-guided choledochoduodenostomy with lumen-apposing metal stents for primary drainage of malignant distal biliary obstruction (SCORPION-IIp): a prospective pilot study.
PubMed 文献 · Gastrointest Endosc · 2024-10-16

本研究为前瞻性单中心先导研究,纳入27例病理确诊的恶性远端胆道梗阻且无胃出口梗阻患者,评估EUS引导下胆管十二指肠吻合术(EUS-CDS)置入腔道适配金属支架(LAMS)后经LAMS置入全覆膜自膨式金属支架(FCSEMS)的一线引流效果。LAMS置入成功24/27(89%),经LAMS置入FCSEMS成功20/24(83%),其余4例置入同轴双猪尾塑料支架。20例中2例出现持续性黄疸需支架翻修(10%),临床成功率90%,初始临床成功后无支架功能障碍发生。

要点

  • EUS-CDS联合LAMS后经LAMS置入FCSEMS的技术成功率为83%(20/24)。
  • 支架功能障碍率为10%(2/20),临床成功率为90%。
  • 初始临床成功后无患者发生支架功能障碍。

核心结论

  • 技术成功的EUS-CDS联合经LAMS置入FCSEMS后支架功能障碍率为10%。
  • 改善LAMS的设计可能进一步降低支架功能障碍率。

研究设计与样本

  • 前瞻性单中心先导研究,纳入27例病理确诊的恶性远端胆道梗阻且无胃出口梗阻的连续患者。
  • 主要结局为支架功能障碍,定义为初始临床成功后复发性黄疸、持续性黄疸伴持续性胆管扩张或胆管炎。

主要发现

  • LAMS置入成功24/27(89%),经LAMS置入FCSEMS成功20/24(83%),其余4例置入同轴双猪尾塑料支架。
  • 20例中2例出现持续性黄疸需支架翻修(10%),临床成功率为90%。
  • 初始临床成功后无患者发生支架功能障碍。

关键数值与推荐

  • 支架功能障碍率10%(2/20)。
  • 临床成功率90%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Biliary drainage by ERCP in patients with malignant distal bile duct obstruction (MBO) is frequently associated with adverse events, such as pancreatitis, hampering patient outcomes. EUS-guided choledochoduodenostomy (EUS-CDS) with a lumen-apposing metal stent (LAMS) is a promising alternative in patients with MBO but is associated with a worrisome risk of stent dysfunction. Placement of a fully covered self-expandable metal stent (FCSEMS) through the LAMS, thereby changing the axis of biliary drainage toward the descending duodenum, may decrease the risk of stent dysfunction while maintaining high technical success and low adverse event rates. METHODS: This was a prospective single-center pilot study in patients with pathology-confirmed MBO without gastric outlet obstruction. The primary outcome was stent dysfunction, defined as recurrent jaundice after initial clinical success, ongoing jaundice in combination with persistent bile duct dilatation, or cholangitis. RESULTS: Overall, 27 consecutive patients eligible for EUS-CDS were enrolled. The placement of a LAMS was successful in 24 of 27 patients (89%), and placement of a FCSEMS through the LAMS was successful in 20 of 24 (83%); in the remaining 4 patients, a coaxial double-pigtail plastic stent was placed. Two of these 20 patients experienced persistent jaundice requiring stent revision (10%), leading to a clinical success rate of 90%. No patients developed stent dysfunction after initial clinical success. CONCLUSIONS: This study showed a stent dysfunction rate of 10% after technically successful EUS-CDS with placement of a FCSEMS through the LAMS. Improving the design of LAMSs may further reduce the rate of stent dysfunction. (Clinical trial registration number: NCT05595122.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Fritzsche JA, Fockens P, Besselink MG, et al. Optimizing EUS-guided choledochoduodenostomy with lumen-apposing metal stents for primary drainage of malignant distal biliary obstruction (SCORPION-IIp): a prospective pilot study. Gastrointest Endosc. 2024. PMID: 39424003. doi:10.1016/j.gie.2024.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。